EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry

Lijiang Zhang, Danyang Liu, Xueying Xiang, Suhang Wu, Congcong Wen iD, Xianqin Wang iD

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 02.11.2026. Verfasst von Lijiang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzh…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Alkaloids. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haplopine, a furoquinoline alkaloid with documented anti‐inflammatory, antioxidant, and anti‐atopic dermatitis properties, has not yet been characterized with respect to its in vivo disposition. Here, we developed a fast UPLC‐MS/MS assay for quantifying haplopine in mouse blood. Aliquots of 20 μL of blood were subjected to acetonitrile‐based protein precipitation and resolved on a BEH C18 column within a 4‐min run. Quantification was performed in the positive‐ion electrospray multiple reaction monitoring mode, monitoring the transitions m/z 246.2 → 231.3 for haplopine and m/z 326.2 → 291.4 for the internal standard. The method was linear over 1–1000 ng/mL ( r 2 = 0.9998), with intra‐ and inter‐day precision below 13% and 11%, respectively; accuracy ranged from 90.2% to 110.8%, recovery exceeded 87.2%, and matrix effects were 92.8%–99.1%. The validated assay was then applied to study the pharmacokinetics of haplopine in mice following intravenous (2.0 mg/kg) and oral (8 and 16 mg/kg) administration. Absolute oral bioavailability reached 39.1% and 55.0% at 8 and 16 mg/kg, respectively, indicating moderate, dose‐dependent systemic bioavailability. Collectively, these data constitute the first pharmacokinetic description of haplopine and provide a foundation for its continued development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAlkaloidsAnimalsMiceChromatography, High Pressure LiquidBiological AvailabilityReproducibility of ResultsMaleLinear ModelsSensitivity and SpecificityLimit of DetectionAdministration, Oral

Stichwörter der Autor:innen

UPLC‐MS/MSbioavailabilityhaplopinemouse bloodpharmacokinetics

Substanzen

Alkaloids

Autor:innen und Institutionen

  • Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Laboratory Animal Center, Wenzhou Medical University, Wenzhou, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Congcong Wen, Xianqin Wang

Zitieren

APA

Zhang, L., Liu, D., Xiang, X., Wu, S., Wen, C., & Wang, X. (2026). Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70652

Vancouver

Zhang L, Liu D, Xiang X, Wu S, Wen C, Wang X. Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70652

BibTeX
@article{Zhang2026,
  author = {Zhang, Lijiang and Liu, Danyang and Xiang, Xueying and Wu, Suhang and Wen, Congcong and Wang, Xianqin},
  title = {Pharmacokinetics and Bioavailability of Haplopine in Mice by Ultra‐High‐Performance Liquid Chromatography–Tandem Mass Spectrometry},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1002/bmc.70652}
}
Kostenlos starten →